HSD17B13 and Hepatic fibrosis: The protection against liver fibrosis conferred by the hydroxysteroid, 17-beta dehydrogenase 13 (HSD17B13), is associated with reduced dihydropyrimidine dehydrogenase-mediated pyrimidine catabolism (Luukkonen et al., 2023).